First patient dosed in Phase 2 ADCAP trial to treat severe cases of pneumonia. The double-blind, placebo-controlled trial will recruit 100 patients in five European countries.
First patient dosed in Phase 2 ADCAP trial to treat severe cases of pneumonia. The double-blind, placebo-controlled trial will recruit 100 patients in five European countries.